Can a potent statin actually regress coronary atherosclerosis?

被引：11

作者：

Blumenthal, RS ^{[1
]}

Kapur, NK ^{[1
]}

机构：

[1] Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD 21287 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 13期

关键词：

D O I：

10.1001/jama.295.13.jed60019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1583 / 1584

页数：2

共 13 条

[1] High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions [J].

Barter, P ;

Kastelein, J ;

Nunn, A ;

Hobbs, R .

ATHEROSCLEROSIS, 2003, 168 (02) :195-211

[2] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[3]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[4] A simplified approach to the management of non-ST-segment elevation acute coronary syndromes [J].

Gluckman, TJ ;

Sachdev, M ;

Schulman, SP ;

Blumenthal, RS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (03) :349-357

[5] A practical and evidence-based approach to cardiovascular disease risk reduction [J].

Gluckman, TJ ;

Baranowski, B ;

Ashen, D ;

Henrikson, CA ;

McAllister, M ;

Braunstein, JB ;

Blumenthal, RS .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (14) :1490-1500

[6] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].

Grundy, SM ;

Cleeman, JI ;

Merz, CNB ;

Brewer, HB ;

Clark, LT ;

Hunninghake, DB ;

Pasternak, RC ;

Smith, SC ;

Stone, NJ .

CIRCULATION, 2004, 110 (02) :227-239

[7] Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[8] Effect of very high-intensity statin therapy on regression of coronary atherosclerosis - The ASTEROID trial [J].

Nissen, SE ;

Nicholls, SJ ;

Sipahi, I ;

Libby, P ;

Raichlen, JS ;

Ballantyne, CM ;

Davignon, J ;

Erbel, R ;

Fruchart, JC ;

Tardif, JC ;

Schoenhagen, P ;

Crowe, T ;

Cain, V ;

Wolski, K ;

Goormastic, M ;

Tuzcu, EM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (13) :1556-1565

[9] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[10] Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial [J].

Nissen, SE ;

Tsunoda, T ;

Tuzcu, EM ;

Schoenhagen, P ;

Cooper, CJ ;

Yasin, M ;

Eaton, GM ;

Lauer, MA ;

Sheldon, WS ;

Grines, CL ;

Halpern, S ;

Crowe, T ;

Blankenship, JC ;

Kerensky, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (17) :2292-2300

← 1 2 →